Colorectal cancer registry in the Brazilian Public Health System, from 2015 to 2023
DOI:
https://doi.org/10.47456/rbps.v26isupl_3.04Keywords:
Rectal Neoplasms, Bowel Cancer, Colon Cancer, Epidemiology, Unified Health System (SUS)Abstract
Introduction: Colorectal cancer is a common neoplasm in individuals over 50 years old, with rising incidence in younger populations. Objectives: Given its high prevalence, assessing epidemiological pattern changes is essential. Method: This observational, descriptive, cross-sectional study analyzed DataSus epidemiological databases on hospitalized colorectal cancer patients in Brazil. Results: Between 2015 and 2023, 683,388 hospitalizations were recorded (422,100 colon; 261,288 rectosigmoid/anal canal), with 50.7% male, 53% white, 31.54% brown, and 4.2% black. The southeast region had the most cases, and 19.7% were under 50 years old. Espírito Santo, with 1.87% of Brazil’s population, accounted for 3.54% of hospitalizations, predominantly brown (61%) and with a higher female prevalence (50.1%). From 2016 to 2023, colon cancer cases increased by 39%, and rectosigmoid/anal canal cancer by 38%. Hospitalizations among black individuals rose by 96%, and cases increased by 29.9% in those under 50 and 41.8% in those over 50. Discussion: Data from DataSus do not align with international studies regarding the early-onset colorectal cancer rise but highlight racial and regional epidemiological differences in Brazil and Espírito Santo. Conclusion: Colorectal cancer is an increasing national burden, controllable through prevention, early diagnosis, and treatment. This study’s epidemiological data indicate regional disparities requiring further investigation.
Downloads
References
1. Dekker E, Tanis PJ, Vleugels JLA, Kasi PM, Wallace MB. Colorectal Cancer. The Lancet [Internet]. 2019 Oct;394(10207):1467–80. Available from: https://pubmed.ncbi.nlm.nih.gov/31631858/
2. Mahmoud NN. Colorectal Cancer. Surgical Oncology Clinics of North America. 2022 Apr;31(2):127–41.
3. Nfonsam V, Wusterbarth E, Gong A, Vij P. Early-Onset Colorectal Cancer. Surgical Oncology Clinics of North America. 2022 Apr;31(2):143–55.
4. Baidoun F, Elshiwy K, Elkeraie Y, Merjaneh Z, Khoudari G, Sarmini MT, et al. Colorectal Cancer Epidemiology: Recent Trends and Impact on Outcomes. Current Drug Targets. 2021 Jun 21;22(9):998–1009.
5. Chan P, Ngu J, Poh Z, Soetikno R. Colorectal cancer screening. Singapore Medical Journal. 2017 Jan;58(1):24–8
6. Primm KM, Andrea Joyce Malabay, Curry T, Chang S. Who, where, when: Colorectal cancer disparities by race and ethnicity, subsite, and stage. Cancer medicine. 2023 May 22;12(13):14767–
7. 80.
8. Mauri G, Sartore‐Bianchi A, Russo A, Marsoni S, Bardelli A, Siena S. Early‐onset colorectal cancer in young individuals. Molecular Oncology. 2018 Dec 22;13(2):109–31.
9. Eng C, Jácome AA, Agarwal R, Hayat MH, Byndloss MX, Holowatyj AN, et al. A comprehensive framework for early-onset colorectal cancer research. The Lancet Oncology. 2022 Jan;
10. Estatísticas de câncer [Internet]. Instituto Nacional de Câncer - INCA. 2022. Available from: https://www.gov.br/inca/pt-br/assuntos/cancer/numeros
11. IBGE. Panorama do Censo 2022 [Internet]. Panorama do Censo 2022. 2022. Available from: https://censo2022.ibge.gov.br/panorama/
12. Resenha Estrutural População, Crescimento, Densidade Demográfica e Domicílios: Um Panorama do Espírito Santo e o Contexto Nacional [Internet]. Available from: https://ijsn.es.gov.br/Media/IJSN/PublicacoesAnexos/resenhas_pdf/IJSN_2023-Resenha_Estrutural_Um%20Panorama%20do%20ES%20e%20o%20contexto%20nacional_EDIT.pdf.
13. Blog sobre pobreza: Blog - Como Superar a Extrema Pobreza No Brasil [Internet]. pontesocial.org.br. [cited 2024 Jul 21]. Available from: https://pontesocial.org.br/post-como-superar-a-extremapobreza?gad_source=1&gclid=CjwKCAjw4_K0BhBsEiwAfVVZ__yo1vBd6CBIxjnclAHOZVVEW6SLg5HH5KSj3S1k2rc-lMdj0Ka6RoCgPIQAvD_BwE.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Brazilian Journal of Health Research
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The Revista Brasileira de Pesquisa em Saúde (RBPS) adopts the CC BY 4.0 license, which means that authors retain the copyright of the works they submit to the journal. Authors are responsible for declaring that their contribution is an original manuscript, that it has not been previously published, and that it is not under simultaneous review by another scientific journal. Upon submitting the manuscript, authors grant RBPS the exclusive right of first publication, subject to peer review.
Authors are permitted to enter into additional contracts for the non-exclusive distribution of the version published by RBPS (for example, in institutional repositories or as a book chapter), provided that due acknowledgment of authorship and of initial publication by RBPS is given. Authors are also encouraged to make their work available online (for example, in institutional repositories or on their personal pages) after its initial publication in the journal, with due acknowledgment of authorship and of the original publication by RBPS.
Accordingly, under the CC BY 4.0 license, readers have the right to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially;
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
The licensor cannot revoke these freedoms as long as you follow the license terms. Under the following terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
